New Biomarker Duo Predicts Colorectal Cancer Outcomes

0

1. Study published in the Journal of Clinical Pathology.

2. Investigated p21 and EGFR roles in CRC.

3. Analyzed 12,319 CRC patients from 2008-2020.

4. High p21 linked to longer survival; high EGFR linked to shorter survival.

5. Used immunohistochemistry for biomarker quantification.

6. Notable correlations found with tumor characteristics.

7. Multivariate analysis identified significant prognostic factors.